Patent ID: 11903984
Assignee: PHI THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 5:
6. The composition of claim 4, wherein the enzyme is one of:
a glycosidase;
a protease;
a DNAse;
a restriction endonuclease;
catalyst of hydrolysis of linear polymers of N-acetyl-D-glucosamines;
a β-hexosaminidase;
hydrolyzes β-1,6-glycosidic linkages of acetylglucosamine polymers;
a restriction endonuclease;
papain;
bromelain;
Trypsin;
Proteinase K;
Subtilisin;
Serratiopeptidase;
Dispersin;
alginate lyase;
amylase;
cellulase;
Dispersin B;
a protease;
an anti-aging enzyme;
superoxide dismutase; or
a peroxidase.